President Trump has rescinded Biden's order aimed at lowering prescription drug costs, raising concerns about potential future increases in prices for Medicare beneficiaries.
Trump's proposed tariffs may raise drug prices and cause shortages, impacting the U.S. pharmaceutical market by increasing the cost and availability of medications.